Multiple Sclerosis Trial, Recruiting (NCT05713890)

Multiple Sclerosis Trial, Recruiting NCT05713890 Sponsor: IRCCS San Raffaele Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT05713890 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Be between 18 and 65 years old
Have a confirmed diagnosis of Multiple Sclerosis (MS) based on recognised medical guidelines (2017 McDonald criteria)
Be able to understand what the study involves and its risks, and be willing to sign a consent form
Be able to use a Virtual Reality (VR) system remotely from home
Have been right-handed before becoming ill (confirm with trial site)
Have some weakness in the right arm or hand as a result of MS
Have some difficulty using the right hand for everyday tasks, such as needing help, supervision, or adjustments to complete daily activities
Have a level of MS-related disability within a specific moderate range, as measured by a standard scoring system (EDSS score between 2.0 and 7.0)
Have little to no problems with balance or coordination related to the cerebellum (confirm with trial site)
Be able to complete a standard hand function test (placing pegs in a board) within a specific time range — not too fast and not too slow (confirm with trial site)

Who may not be able to join:

Have a reason why an MRI scan would not be safe for them (e.g., a metal implant)
Have significant vision problems that would prevent them from seeing VR content
Be experiencing moderate to severe pain (a pain score of 4 or more out of 10)
Have another significant neurological, psychiatric, or serious physical health condition besides MS
Have had an MS relapse or taken steroid medication in the past 3 months
Have had a change in symptom-related medication or botulinum toxin (e.g., Botox) injections in the arm in the past 3 months
Have been on their current MS disease-modifying treatment for 6 months or less
Have received any rehabilitation treatment in the past 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria A Rocca, MD, IRCCS Ospedale San Raffaele

Phone: 0226433019

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05713890

Sponsor: IRCCS San Raffaele

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 0226433019

More information: https://clinicaltrials.gov/study/NCT05713890

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Be between 18 and 65 years old
Have a confirmed diagnosis of Multiple Sclerosis (MS) based on recognised medical guidelines (2017 McDonald criteria)
Be able to understand what the study involves and its risks, and be willing to sign a consent form
Be able to use a Virtual Reality (VR) system remotely from home
Have been right-handed before becoming ill (confirm with trial site)
Have some weakness in the right arm or hand as a result of MS
Have some difficulty using the right hand for everyday tasks, such as needing help, supervision, or adjustments to complete daily activities
Have a level of MS-related disability within a specific moderate range, as measured by a standard scoring system (EDSS score between 2.0 and 7.0)
Have little to no problems with balance or coordination related to the cerebellum (confirm with trial site)
Be able to complete a standard hand function test (placing pegs in a board) within a specific time range — not too fast and not too slow (confirm with trial site)

Who may not be able to join:

Have a reason why an MRI scan would not be safe for them (e.g., a metal implant)
Have significant vision problems that would prevent them from seeing VR content
Be experiencing moderate to severe pain (a pain score of 4 or more out of 10)
Have another significant neurological, psychiatric, or serious physical health condition besides MS
Have had an MS relapse or taken steroid medication in the past 3 months
Have had a change in symptom-related medication or botulinum toxin (e.g., Botox) injections in the arm in the past 3 months
Have been on their current MS disease-modifying treatment for 6 months or less
Have received any rehabilitation treatment in the past 3 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS San Raffaele

Registry

ClinicalTrials.gov

Start date

2 November 2023

Est. completion

1 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in right hand Nine-hole peg test (9HPT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov